PTPRC and neoplasm: In parallel with our study, the enhanced anti-tumor effect in combination treatment was mediated by the increased infiltration of CD45+ immune cells, CD4+ and CD8+ TILs in addition to decreased percentage of CD11b+ Ly6G+ cells.